Sanford H. Barsky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sanford H. Barsky has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Mai Nguyen
4 shared publicationsMary L. Alpaugh
3 shared publicationsShikha Bose
Department of Pathology and UCLA/Revlon Breast Center, UCLA School of Medicine, Los Angeles, California
2 shared publicationsZhi‐Ming Shao
Department of Pathology and UCLA/Revlon Breast Center, UCLA School of Medicine, Los Angeles, California
2 shared publicationsAndrea Kim
1 shared publicationCammy M. Hacker
1 shared publication
Latest Publications
- 1 April 2003
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 74 (2) , 113-122
Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype
- 1 April 2003
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 74 (2) , 113-122
Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype
- 1 January 2003
- Published by Hindawi Limited in The Breast Journal
- Vol. 9 (1) , 39-40
Atypical Ductal Hyperplasia Presenting as Pseudomicrocalcifications
A 53‐year‐old white female on mammography had “suspicious” microcalcifications. Upon excision, these turned out to be pseudomicrocalcifications created by the intraductal cellular proliferations of atypical ductal hyperplasia so dense as to create radiodensities.
- 1 January 2003
- Published by Hindawi Limited in The Breast Journal
- Vol. 9 (1) , 39-40
Atypical Ductal Hyperplasia Presenting as Pseudomicrocalcifications
A 53‐year‐old white female on mammography had “suspicious” microcalcifications. Upon excision, these turned out to be pseudomicrocalcifications created by the intraductal cellular proliferations of atypical ductal hyperplasia so dense as to create radiodensities.
- 1 September 2002
- Published by Wolters Kluwer Health in Laboratory Investigation
- Vol. 15 (9) , 958-972
MUC2 Is a Molecular Marker for Pseudomyxoma Peritonei
Modern Pathology features diagnostic anatomic pathology and contains original scientific papers, selected short courses, appropriate special lectures, reviews, editorials, letters to the editor, and Academy News. In many ways, it reflects the instructive and informative composition of the Academy's annual meeting. Publication is monthly.
- 1 September 2002
- Published by Wolters Kluwer Health in Laboratory Investigation
- Vol. 15 (9) , 958-972
MUC2 Is a Molecular Marker for Pseudomyxoma Peritonei
Modern Pathology features diagnostic anatomic pathology and contains original scientific papers, selected short courses, appropriate special lectures, reviews, editorials, letters to the editor, and Academy News. In many ways, it reflects the instructive and informative composition of the Academy's annual meeting. Publication is monthly.
- 1 December 2000
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 279 (1) , 116-123
Myoepithelial-Specific CD44 Shedding Is Mediated by a Putative Chymotrypsin-like Sheddase
- 1 December 2000
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 279 (1) , 116-123
Myoepithelial-Specific CD44 Shedding Is Mediated by a Putative Chymotrypsin-like Sheddase
- 1 November 1999
- Published by Hindawi Limited in The Breast Journal
- Vol. 5 (6) , 407-412
Should LCIS Be Regarded as a Heterogeneous Disease?
Click on the article title to read more.
- 1 November 1999
- Published by Hindawi Limited in The Breast Journal
- Vol. 5 (6) , 407-412
Should LCIS Be Regarded as a Heterogeneous Disease?
Click on the article title to read more.
- 5 January 1999
- Published by Hindawi Limited in The Breast Journal
- Vol. 5 (1) , 70-72
Eric R. Frykberg, MD, FACS. Should DCIS Be Renamed Carcinoma of the Ductal System?
- 5 January 1999
- Published by Hindawi Limited in The Breast Journal
- Vol. 5 (1) , 70-72
Eric R. Frykberg, MD, FACS. Should DCIS Be Renamed Carcinoma of the Ductal System?
- Open Access
- 19 August 1998
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 90 (16) , 1198-1205
Histopathologic and Molecular Alterations in Bronchial Epithelium in Habitual Smokers of Marijuana, Cocaine, and/or Tobacco
Background: Tobacco smoking has been observed to cause molecular alterations in bronchial epithelium that antedate the development of lung carcinoma. The rising prevalence of marijuana and cocaine use among young adults in the United States prompted us to investigate whether similar molecular and histopathologic alterations occur in habitual smokers of marijuana and/or cocaine who may or may not also smoke tobacco. Methods: Bronchoscopy was performed in 104 healthy volunteer subjects, including 28 nonsmokers and 76 smokers of one or more of the following substances: marijuana, tobacco, and/or cocaine. Bronchial mucosa biopsy specimens and brushings were analyzed for histopathologic changes, for immunohistopathologic expression of intermediate or surrogate end-point markers that are linked to an increased risk of cancer (Ki-67 [a marker of cell proliferation], epidermal growth factor receptor, p53, Her-2/neu [also known as erbB-2 and ERBB2], globular actin, and abnormal DNA ploidy). Reported P values are two-sided. Results: Smokers of any one substance or of two or more substances exhibited more alterations than nonsmokers in five to nine of the 10 histopathologic parameters investigated (all P<.05), and they exhibited more molecular abnormalities than nonsmokers. Differences between smokers and nonsmokers were statistically significant (all P⩽.01) for Ki-67, epidermal growth factor receptor, globular actin, and DNA ploidy. There was general agreement between the presence of molecular abnormalities and histopathologic alterations; however, when disagreement occurred, the molecular abnormalities (e.g., Ki-67 and epidermal growth factor receptor) were more frequently altered (all P⩽.01). Conclusions: These findings suggest that smoking marijuana and/or cocaine, like tobacco smoking, exerts field cancerization effects on bronchial epithelium, which may place smokers of these substances at increased risk for the subsequent development of lung cancer. [J Natl Cancer Inst 1998;90:1198–1205]
- 19 August 1998
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 90 (16) , 1198-1205
Open AccessHistopathologic and Molecular Alterations in Bronchial Epithelium in Habitual Smokers of Marijuana, Cocaine, and/or Tobacco
Background: Tobacco smoking has been observed to cause molecular alterations in bronchial epithelium that antedate the development of lung carcinoma. The rising prevalence of marijuana and cocaine use among young adults in the United States prompted us to investigate whether similar molecular and histopathologic alterations occur in habitual smokers of marijuana and/or cocaine who may or may not also smoke tobacco. Methods: Bronchoscopy was performed in 104 healthy volunteer subjects, including 28 nonsmokers and 76 smokers of one or more of the following substances: marijuana, tobacco, and/or cocaine. Bronchial mucosa biopsy specimens and brushings were analyzed for histopathologic changes, for immunohistopathologic expression of intermediate or surrogate end-point markers that are linked to an increased risk of cancer (Ki-67 [a marker of cell proliferation], epidermal growth factor receptor, p53, Her-2/neu [also known as erbB-2 and ERBB2], globular actin, and abnormal DNA ploidy). Reported P values are two-sided. Results: Smokers of any one substance or of two or more substances exhibited more alterations than nonsmokers in five to nine of the 10 histopathologic parameters investigated (all P<.05), and they exhibited more molecular abnormalities than nonsmokers. Differences between smokers and nonsmokers were statistically significant (all P⩽.01) for Ki-67, epidermal growth factor receptor, globular actin, and DNA ploidy. There was general agreement between the presence of molecular abnormalities and histopathologic alterations; however, when disagreement occurred, the molecular abnormalities (e.g., Ki-67 and epidermal growth factor receptor) were more frequently altered (all P⩽.01). Conclusions: These findings suggest that smoking marijuana and/or cocaine, like tobacco smoking, exerts field cancerization effects on bronchial epithelium, which may place smokers of these substances at increased risk for the subsequent development of lung cancer. [J Natl Cancer Inst 1998;90:1198–1205]
- 1 June 1998
- Published by Elsevier in Experimental Cell Research
- Vol. 241 (2) , 394-403
The Human Myoepithelial Cell Exerts Antiproliferative Effects on Breast Carcinoma Cells Characterized by p21WAF1/CIP1Induction, G2/M Arrest, and Apoptosis
- 1 June 1998
- Published by Elsevier in Experimental Cell Research
- Vol. 241 (2) , 394-403
The Human Myoepithelial Cell Exerts Antiproliferative Effects on Breast Carcinoma Cells Characterized by p21WAF1/CIP1Induction, G2/M Arrest, and Apoptosis
- Open Access
Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran